The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy

T. Shimoike, Toyoshi Inoguchi, F. Umeda, H. Nawata, K. Kawano, H. Ochi

    Research output: Contribution to journalArticle

    68 Citations (Scopus)

    Abstract

    It has been reported that advanced glycosylation end products (AGEs) play an important role in the development of diabetic complications. To evaluate the relationship between serum AGEs and diabetic nephropathy, we measured serum AGE levels in diabetic patients with normoalbuminuria (N), microalbuminuria (M), overt proteinuria (O), and hemodialysis (HD), non diabetic patients with nephropathy, and age-matched control subjects using the enzyme-linked immunosorbent assay (ELISA). Urine AGE levels were also measured in these subjects except group HD. Serum AGE levels in diabetic patients were not significantly higher than those in the normal subjects. When we compared serum AGE levels among various stages of diabetic nephropathy, groups O and HD had significantly higher serum AGE levels than the other groups. Serum AGE levels in group HD were almost 6-fold higher than those in groups N and M. In contrast, there were no significant differences in urinary AGE levels among any diabetic groups. As for the variables that determine serum AGE levels in diabetic patients, there was no significant correlation between serum AGEs and fasting blood glucose, hemoglobin A 1 (c) (HbA 1 (c)), or duration of diabetes. In contrast, serum AGEs showed a strong correlation with serum creatinine and an inverse correlation with creatinine clearance. To evaluate the relationship between serum AGEs and oxidative stress in diabetic nephropathy, urinary 8-hydroxy-2'-deoxyguanosine (8-OHdG) and serum malondialdehyde (MDA), which are biological markers of total oxidative stress in vivo, were also examined. Both urinary 8-OHdG and serum MDA levels were significantly higher in diabetic patients with proteinuria versus those without proteinuria. However, there was no significant correlation between serum AGEs and urinary 8-OHdG or serum MDA levels in diabetic patients. These results suggest that the accumulation of serum AGEs in diabetic nephropathy may be mainly due to decreased removal in the kidney rather than increased production by high glucose levels or oxidative stress. Copyright (C) 2000 by W.B. Saunders Company.

    Original languageEnglish
    Pages (from-to)1030-1035
    Number of pages6
    JournalMetabolism: Clinical and Experimental
    Volume49
    Issue number8
    DOIs
    Publication statusPublished - Jan 1 2000

    Fingerprint

    Advanced Glycosylation End Products
    Diabetic Nephropathies
    Serum
    Renal Dialysis
    Malondialdehyde
    Proteinuria
    Oxidative Stress
    Creatinine
    Glycosylated Hemoglobin A
    Diabetes Complications

    All Science Journal Classification (ASJC) codes

    • Endocrinology, Diabetes and Metabolism
    • Endocrinology

    Cite this

    The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy. / Shimoike, T.; Inoguchi, Toyoshi; Umeda, F.; Nawata, H.; Kawano, K.; Ochi, H.

    In: Metabolism: Clinical and Experimental, Vol. 49, No. 8, 01.01.2000, p. 1030-1035.

    Research output: Contribution to journalArticle

    Shimoike, T, Inoguchi, T, Umeda, F, Nawata, H, Kawano, K & Ochi, H 2000, 'The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy', Metabolism: Clinical and Experimental, vol. 49, no. 8, pp. 1030-1035. https://doi.org/10.1053/meta.2000.7738
    Shimoike, T. ; Inoguchi, Toyoshi ; Umeda, F. ; Nawata, H. ; Kawano, K. ; Ochi, H. / The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy. In: Metabolism: Clinical and Experimental. 2000 ; Vol. 49, No. 8. pp. 1030-1035.
    @article{b2a5a57329544972a1e65f56ac36a50a,
    title = "The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy",
    abstract = "It has been reported that advanced glycosylation end products (AGEs) play an important role in the development of diabetic complications. To evaluate the relationship between serum AGEs and diabetic nephropathy, we measured serum AGE levels in diabetic patients with normoalbuminuria (N), microalbuminuria (M), overt proteinuria (O), and hemodialysis (HD), non diabetic patients with nephropathy, and age-matched control subjects using the enzyme-linked immunosorbent assay (ELISA). Urine AGE levels were also measured in these subjects except group HD. Serum AGE levels in diabetic patients were not significantly higher than those in the normal subjects. When we compared serum AGE levels among various stages of diabetic nephropathy, groups O and HD had significantly higher serum AGE levels than the other groups. Serum AGE levels in group HD were almost 6-fold higher than those in groups N and M. In contrast, there were no significant differences in urinary AGE levels among any diabetic groups. As for the variables that determine serum AGE levels in diabetic patients, there was no significant correlation between serum AGEs and fasting blood glucose, hemoglobin A 1 (c) (HbA 1 (c)), or duration of diabetes. In contrast, serum AGEs showed a strong correlation with serum creatinine and an inverse correlation with creatinine clearance. To evaluate the relationship between serum AGEs and oxidative stress in diabetic nephropathy, urinary 8-hydroxy-2'-deoxyguanosine (8-OHdG) and serum malondialdehyde (MDA), which are biological markers of total oxidative stress in vivo, were also examined. Both urinary 8-OHdG and serum MDA levels were significantly higher in diabetic patients with proteinuria versus those without proteinuria. However, there was no significant correlation between serum AGEs and urinary 8-OHdG or serum MDA levels in diabetic patients. These results suggest that the accumulation of serum AGEs in diabetic nephropathy may be mainly due to decreased removal in the kidney rather than increased production by high glucose levels or oxidative stress. Copyright (C) 2000 by W.B. Saunders Company.",
    author = "T. Shimoike and Toyoshi Inoguchi and F. Umeda and H. Nawata and K. Kawano and H. Ochi",
    year = "2000",
    month = "1",
    day = "1",
    doi = "10.1053/meta.2000.7738",
    language = "English",
    volume = "49",
    pages = "1030--1035",
    journal = "Metabolism: Clinical and Experimental",
    issn = "0026-0495",
    publisher = "W.B. Saunders Ltd",
    number = "8",

    }

    TY - JOUR

    T1 - The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy

    AU - Shimoike, T.

    AU - Inoguchi, Toyoshi

    AU - Umeda, F.

    AU - Nawata, H.

    AU - Kawano, K.

    AU - Ochi, H.

    PY - 2000/1/1

    Y1 - 2000/1/1

    N2 - It has been reported that advanced glycosylation end products (AGEs) play an important role in the development of diabetic complications. To evaluate the relationship between serum AGEs and diabetic nephropathy, we measured serum AGE levels in diabetic patients with normoalbuminuria (N), microalbuminuria (M), overt proteinuria (O), and hemodialysis (HD), non diabetic patients with nephropathy, and age-matched control subjects using the enzyme-linked immunosorbent assay (ELISA). Urine AGE levels were also measured in these subjects except group HD. Serum AGE levels in diabetic patients were not significantly higher than those in the normal subjects. When we compared serum AGE levels among various stages of diabetic nephropathy, groups O and HD had significantly higher serum AGE levels than the other groups. Serum AGE levels in group HD were almost 6-fold higher than those in groups N and M. In contrast, there were no significant differences in urinary AGE levels among any diabetic groups. As for the variables that determine serum AGE levels in diabetic patients, there was no significant correlation between serum AGEs and fasting blood glucose, hemoglobin A 1 (c) (HbA 1 (c)), or duration of diabetes. In contrast, serum AGEs showed a strong correlation with serum creatinine and an inverse correlation with creatinine clearance. To evaluate the relationship between serum AGEs and oxidative stress in diabetic nephropathy, urinary 8-hydroxy-2'-deoxyguanosine (8-OHdG) and serum malondialdehyde (MDA), which are biological markers of total oxidative stress in vivo, were also examined. Both urinary 8-OHdG and serum MDA levels were significantly higher in diabetic patients with proteinuria versus those without proteinuria. However, there was no significant correlation between serum AGEs and urinary 8-OHdG or serum MDA levels in diabetic patients. These results suggest that the accumulation of serum AGEs in diabetic nephropathy may be mainly due to decreased removal in the kidney rather than increased production by high glucose levels or oxidative stress. Copyright (C) 2000 by W.B. Saunders Company.

    AB - It has been reported that advanced glycosylation end products (AGEs) play an important role in the development of diabetic complications. To evaluate the relationship between serum AGEs and diabetic nephropathy, we measured serum AGE levels in diabetic patients with normoalbuminuria (N), microalbuminuria (M), overt proteinuria (O), and hemodialysis (HD), non diabetic patients with nephropathy, and age-matched control subjects using the enzyme-linked immunosorbent assay (ELISA). Urine AGE levels were also measured in these subjects except group HD. Serum AGE levels in diabetic patients were not significantly higher than those in the normal subjects. When we compared serum AGE levels among various stages of diabetic nephropathy, groups O and HD had significantly higher serum AGE levels than the other groups. Serum AGE levels in group HD were almost 6-fold higher than those in groups N and M. In contrast, there were no significant differences in urinary AGE levels among any diabetic groups. As for the variables that determine serum AGE levels in diabetic patients, there was no significant correlation between serum AGEs and fasting blood glucose, hemoglobin A 1 (c) (HbA 1 (c)), or duration of diabetes. In contrast, serum AGEs showed a strong correlation with serum creatinine and an inverse correlation with creatinine clearance. To evaluate the relationship between serum AGEs and oxidative stress in diabetic nephropathy, urinary 8-hydroxy-2'-deoxyguanosine (8-OHdG) and serum malondialdehyde (MDA), which are biological markers of total oxidative stress in vivo, were also examined. Both urinary 8-OHdG and serum MDA levels were significantly higher in diabetic patients with proteinuria versus those without proteinuria. However, there was no significant correlation between serum AGEs and urinary 8-OHdG or serum MDA levels in diabetic patients. These results suggest that the accumulation of serum AGEs in diabetic nephropathy may be mainly due to decreased removal in the kidney rather than increased production by high glucose levels or oxidative stress. Copyright (C) 2000 by W.B. Saunders Company.

    UR - http://www.scopus.com/inward/record.url?scp=0033886339&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=0033886339&partnerID=8YFLogxK

    U2 - 10.1053/meta.2000.7738

    DO - 10.1053/meta.2000.7738

    M3 - Article

    C2 - 10954022

    AN - SCOPUS:0033886339

    VL - 49

    SP - 1030

    EP - 1035

    JO - Metabolism: Clinical and Experimental

    JF - Metabolism: Clinical and Experimental

    SN - 0026-0495

    IS - 8

    ER -